Stanford Medicine today reports on the results of the study Apple Heart Study, the world's largest such study, which spanned more than 400,000 participants from all 50 states for eight months. Apple and Stanford created a study to evaluate the irregular rhythmic notification of the Apple Watch, which sometimes checks the heart rate in the background and sends a message if the irregular heart rate is reminiscent of atrial fibrillation (AFib). As part of the study, if irregular heartbeat was detected, participants received notifications about their Apple Watch and iPhone, consultations with telemedicine with a doctor and an electrocardiogram (ECG) patch for additional monitoring.
"We are proud to work with Stanford's medicine as they carry out this important study and are looking forward to hearing more about the impact of Apple Watch with the medical community," said Jeff Williams, Apple's chief operating officer. "We hope that consumers will continue to receive useful and effective information about their health through Apple Watch."
Researchers at Stanford's Medicine presented their findings today at the 68th Annual Scientific Session of the American College of Cardiology and Expo. The results of the study showed that 0.5% of more than 400,000 participants received a report of irregular heartbeat, illustrating the ability to provide important medical information to the user without causing unnecessary stress on their physician's schedule. Many participants sought medical advice after their irregular rhythmic message, using information to have more substantiated conversations with their doctors.
"As doctors, we are always trying to find ways to offer patients the health information they care about for individualized care," said Sambul Desai, MD, Apple's Vice President for Health Care & I am "The vision of medical research reflects what we hear from consumers, and we are glad to see how Apple Watch helps more consumers in the future, in collaboration with the medical community for further research."